Dr Sofra worked with Gerald Pollock, the co-inventor of the first pacemaker, to further develop Dr Pollock's London University invention, the Ion Magnum, which started in 1975 and was completed in 2008 based on his combined research with D. Gilbert, a molecular biology London University professor after around 33 years of empirical research. The technology features a proprietary formula that synthesizes signals that reach the brain because of their compatibility with the Central Nervous System (CNS) The brain reacts as it would during regular strenuous exercise mode, by 1/ ordering a full body contraction, and 2/ by releasing hormones that boost metabolism, suppress hunger, increase muscle mass and testosterone while detoxing.  The device generates the complex sensations of a multi-exercise regimen, that includes fast-paced or slow/resistance physical training, horse riding and belly dancing.

 An examination of 56 clinical studies and 3 books on the Virtual Gym, found the following values which were adjusted to be within the normal range and statistically significant on all combined samples examined of a total of 147 patients. ‚Äč
1.     No fatty liver on Sonography Reports after 12 Tx
2.     Visceral Fat decrease: -43.8. 
3.     Muscle mass increase: +49.5%  
4.     C-reactive protein -- inflammation decrease: -37.88% 
5.     Cortisol decrease -- Stress Reduction: -18.42%
6.     Testosterone Increase -- Mood, Energy, Sexuality Boost: +42.23% in women; 63.9% in men
7.     IGF-! Increase -- muscle growth, collagen increase: 19.68%
8.     HDL normalized increase -- Good cholesterol: +49.12%
9.     Triglycerides decrease -- Bad cholesterol: -40.84% 
10.   VLDL decrease -- Bad cholesterol: -41.59% 
11.   Free T3 increase -- Metabolism boost: +40.78% 
12.   Creatinine decrease -- healthy liver and kidneys -19.67% 
13.   Bilirubin decrease -- healthy liver and kidneys: -69.23%  
14.   ALT (alanine aminotransferase) decrease -- healthy liver: -24.83%
15.   AST (aspartate aminotransferase) decrease -- healthy liver: -30.407%
16.   ALP (alkaline phosphatase) decrease -- healthy liver: -14.529% 
17.   Fasting Glucose Decrease -- improved diabetic status:- 38.44%
18.   Postprandial Glucose Decrease -- improved diabetic status: -39.01% 
19.   Fasting Insulin Decrease -- improved diabetic status: -41.8%
20.   Postprandial Insulin Decrease -- improved diabetic status: -44.07%
21.   Leptin Increase -- appetite control: +10.8%
22.   Ghrelin decrease -- appetite control: -10.8%1. 
23.  Documented Energy Increase and hunger suppression